Scarica l'app Stockscreener
1.36
9.68%
0.12
Precedente Chiudi:
$1.24
Aprire:
$1.25
Volume 24 ore:
1.37M
Relative Volume:
1.88
Capitalizzazione di mercato:
$171.66M
Reddito:
$108.81M
Utile/perdita netta:
$-186.70M
Rapporto P/E:
-1.6152
EPS:
-0.842
Flusso di cassa netto:
$-16.83M
1 W Prestazione:
+15.25%
1M Prestazione:
+30.77%
6M Prestazione:
-5.56%
1 anno Prestazione:
-33.00%
Intervallo 1D:
$1.23
$1.36
Intervallo di 1 settimana:
$1.18
$1.36
Portata 52W:
$0.85
$2.11
Organigram Global Inc Stock (OGI) Company Profile
Confronta OGI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OGI
Organigram Global Inc
|
1.36 | 157.86M | 108.81M | -186.70M | -16.83M | -0.842 |
|
HLN
Haleon Plc Adr
|
10.80 | 48.39B | 14.35B | 1.85B | 0 | 0.4023 |
|
ZTS
Zoetis Inc
|
163.04 | 70.91B | 9.29B | 2.52B | 2.28B | 5.57 |
|
RDHL
Redhill Biopharma Ltd Adr
|
1.85 | 3.54M | 35.75M | 11.57M | -26.25M | -3.8069 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.11 | 45.20B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.94 | 19.42B | 16.54B | -1.64B | 749.00M | -1.45 |
Organigram Global Inc Stock (OGI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-17 | Ripresa | Canaccord Genuity | Speculative Buy |
| 2024-04-15 | Aggiornamento | Alliance Global Partners | Neutral → Buy |
| 2023-01-13 | Aggiornamento | Stifel | Hold → Buy |
| 2022-01-12 | Aggiornamento | Canaccord Genuity | Hold → Speculative Buy |
| 2021-05-11 | Aggiornamento | CIBC | Sector Underperform → Neutral |
| 2021-04-14 | Downgrade | CIBC | Neutral → Sector Underperform |
| 2021-04-08 | Aggiornamento | BMO Capital Markets | Underperform → Market Perform |
| 2021-03-10 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| 2021-01-13 | Downgrade | Alliance Global Partners | Buy → Neutral |
| 2021-01-13 | Downgrade | Canaccord Genuity | Speculative Buy → Hold |
| 2020-07-07 | Iniziato | Alliance Global Partners | Buy |
| 2020-01-15 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-01-13 | Iniziato | BofA/Merrill | Underperform |
| 2020-01-09 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2019-11-12 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2019-11-05 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-10-11 | Aggiornamento | Jefferies | Hold → Buy |
Mostra tutto
Organigram Global Inc Borsa (OGI) Ultime notizie
This Week In Cannabis: Earnings Season, Uruguay's 'Pepe' Mujica's Legacy, DEA's Meme Backlash, California's Tax Hike, The DEA's Stance And More - Benzinga
Organigram Global Reports Record Q2 2025 Revenues As Global Footprint Expands - Seeking Alpha
Buy Organigram for big returns, Haywood says - Cantech Letter
Organigram Reports Second Quarter Fiscal 2025 Results - mg Magazine
Organigram Global Inc. (NASDAQ:OGI) Q2 2025 Earnings Call Transcript - Insider Monkey
Organigram Global Inc (OGI) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Expansion - Yahoo
Organigram Global’s Earnings Call Highlights Growth and Market Leadership - TipRanks
OrganiGram (OGI) Reports Q2 Loss, Beats Revenue Estimates (Revised) - Yahoo Finance
OrganiGram: Fiscal Q2 Earnings Snapshot - MySA
Organigram has sights set on global expansion after ‘record’ quarter - BNN Bloomberg
Organigram reports spike in sales, revenue from Motif acquisition - StratCann
Organigram Q2 2025 Earnings Call Transcript - MarketBeat
OrganiGram Q2 2025 presentation slides: record revenue, strategic acquisitions fuel growth - Investing.com India
Earnings call transcript: OrganiGram’s Q2 2025 revenue surges 74% By Investing.com - Investing.com Nigeria
Organigram Lights Up Q2 With 74% Sales Surge, Profitable TurnOrganigram Global (NASDAQ:OGI) - Benzinga
Organigram reports record Q2 fiscal 2025 results - MSN
Organigram reports record Q2 fiscal 2025 results | 2025-05-12 | Investing News - Stockhouse
Earnings call transcript: OrganiGram’s Q2 2025 revenue surges 74% - Investing.com
OrganiGram (OGI) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Organigram Q2 Was Better Than Expected - New Cannabis Ventures
Organigram Reports Record Second Quarter Fiscal 2025 Results | O - GuruFocus
Organigram Reports Record Second Quarter Fiscal 2025 Results | OGI Stock News - GuruFocus
Organigram Reports Record Second Quarter Fiscal 2025 Results - Business Wire
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
SA Asks: What are the best cannabis stocks right now? (CGC:NASDAQ) - Seeking Alpha
Is It Time to Turn Bullish on AMD Stock? - The Globe and Mail
Organigram’s Collective Project Wins Big at 2025 High Spirits Awards - TipRanks
Organigram Global's Collective Project Wins Big at the 2025 High Spirits Awards in California | OGI Stock News - GuruFocus
Organigram Global’s Collective Project Wins Big at the 2025 High Spirits Awards in California - Business Wire
Organigram Global Wins ‘Exporter of the Year’ at 2025 New Brunswick Export Awards - mg Magazine
Organigram Global Wins “Exporter of the Year” at the 2025 New Brunswick Export Awards | OGI Stock News - GuruFocus
Organigram Global Wins “Exporter of the Year” at the 2025 New Brunswick Export Awards - Business Wire
Organigram to Report Second Quarter Fiscal 2025 Results on May 1 - GuruFocus
Organigram to Announce Q2 Fiscal 2025 Results on May 12 - TipRanks
Organigram to Report Second Quarter Fiscal 2025 Results on May 12, 2025 | OGI Stock News - GuruFocus
Organigram to Report Second Quarter Fiscal 2025 Results on May 12, 2025 - Business Wire
Organigram Closes Third Tranche of Previously Announced BAT Private Placement Investment - ADVFN
Organigram Calls for Government Support in Cannabis Sector Growth - TipRanks
Organigram Global Congratulates Mark Carney on Election Win - The Globe and Mail
Crane’s (NYSE:CR) Q1 Sales Top Estimates - The Globe and Mail
Organigram Global’s Products Recognized at CNB Awards - mg Magazine
Organigram Global's Products Recognized at the CNB Awards | OGI Stock News - GuruFocus
Organigram’s Brands Shine at Cannabis Awards - TipRanks
Organigram Global’s Products Recognized at the CNB Awards - StreetInsider
3 Profitable Stocks with Solid Fundamentals - The Globe and Mail
Why Pre-Rolls Are Cannabis' Most Profitable Format, From California To Canada - Benzinga
Organigram Global Shares Insights from OG Investor Session - TipRanks
Organigram Global Shares Recording of its OG Investor Session | OGI Stock News - GuruFocus
Organigram Global Shares Recording of its OG Investor Session – Company Announcement - Financial Times
Organigram Global Shares Recording of its OG Investor Session - The Joplin Globe
Organigram Global: Top 10 Undervalued Drug Manufacturers Industry Stocks (OGI) - The Globe and Mail
Organigram Global Inc Azioni (OGI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):